An Act relative to collaborative drug therapy management optimization
Generates a plain-language summary of the bill text and history.
| Date | Branch | Action |
|---|---|---|
| 4/15/2026 | House | Committee recommended bill ought to pass and referred to the committee on House Ways and Means |
| 3/19/2026 | House | Reporting date extended to Monday, June 15, 2026 |
| 12/8/2025 | House | Reporting date extended to Wednesday, March 18, 2026 |
| 7/24/2025 | House | Reported favorably by committee and referred to the committee on Health Care Financing |
| 6/6/2025 | Joint | Hearing scheduled for 06/11/2025 from 01:00 PM-05:00 PM in A-1 |
| 2/27/2025 | Senate | Senate concurred |
| 2/27/2025 | House | Referred to the committee on Public Health |
| Committee | Recommendation | Vote |
|---|---|---|
| J16 | Favorable | 1 entries |
| J24 | Favorable | 1 entries |
| Committee | Fiscal Amount |
|---|---|
| J24 | {'FiscalType': None, 'Amount': 'More Than 100,000.00 '} |
Notwithstanding section 24 B1/2 of chapter 112 of the General Laws or any other general or special laws to the contrary, collaborative drug therapy management may be allowed in ambulatory care clinics licensed pursuant to section 51 of chapter 111 of the General Laws if: (i) there is on-site or off-site supervision by the attending physician and a collaborating pharmacist; and (ii) collaborative drug therapy management is approved by the ambulatory care clinic's medical staff executive committee or designee or medical director or designee.
Notwithstanding section 24 B1/2 of chapter 112 of the General Laws or any other general or special laws to the contrary, collaborative drug therapy management may be allowed in ambulatory care clinics licensed pursuant to section 51 of chapter 111 of the General Laws if: (i) there is on-site or off-site supervision by the attending physician and a collaborating pharmacist; and (ii) collaborative drug therapy management is approved by the ambulatory care clinic's medical staff executive committee or designee or medical director or designee.